Drug Manufacturers - Specialty & Generic | Healthcare
Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acidic and allied products comprising sulphuric acid, sulphur trioxide, oleum, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.
Market Cap
84988067840
Current Price
937.7
52 Week Range
551.05 - 949.5
Previous Close
923.5
Open
923.5
Sector
Healthcare
Address
204, Udyog Kshetra, 2nd Floor Mulund-Goregaon Link Road L.B.S. Marg, Mulund (West), Mumbai, 400 080, India
Phone
+91-22694-36100
Fax
+91-22679-76660
Website
https://www.aartipharmalabs.com
Day Low
923.45
Day High
946.9
Dividend Yield
0.38
PE Ratio
30.764437
Earnings Per Share
30.48
Beta
-0.415
EBITDA
4643706880
Book Value
219.622
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Ms. Hetal Gogri Gala | Vice Chairperson & MD | 49 | 1975 |
Mr. Narendra Jagannath Salvi | MD & Director | 60 | 1964 |
Mr. Piyush P. Lakhani | Chief Financial Officer | - | - |
Mr. G.M. Naidu | Head of Operations & Manufacturing, CDMO & CMO | - | - |
Mr. Sudhakar Shetty | Senior General Manager of HR & Admin | - | - |
Mr. Jeevan Bhargav Mondkar | Company Secretary & Compliance Officer | - | - |
Dr. B. S. Patravale | President of R&D | - | - |
Mr. Jasmin Mehta | Head of Business Development & Direct Procurement | - | - |
Mr. Sachin Patil | Head of API Export Regulated and R&D Management | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.